DJIA 17,813.39 1.20 0.01%
NASDAQ 5,116.14 13.34 0.26%
S&P 500 2,088.87 -0.27 -0.01%
market minute promo

Johnson & Johnson (NYSE: JNJ)

101.96 -0.08 (-0.08%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

JNJ $101.96 -0.08%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $102.17
Previous Close $102.04
Daily Range $101.96 - $102.33
52-Week Range $81.79 - $108.99
Market Cap $282.1B
P/E Ratio 19.55
Dividend (Yield) $3.00 (2.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,401,228
Average Daily Volume 7,295,428
Current FY EPS $6.18




Drug Makers

Johnson & Johnson (JNJ) Description

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices. Website:

News & Commentary Rss Feed

How Johnson & Johnson Spent $71 Billion in 12 Months

A slideshow reveals three interesting points about the pharmaceutical giant.

SPY Vs. Dividend Growth Portfolio

Arrowhead Research: Some Questions For Management

The Schwab U.S. Dividend Equity ETF Is Better Than Social Security

Johnson & Johnson's Latest FDA Approval Could Spell Problems for Amgen

Johnson & Johnson's newly approved multiple myeloma drug, Darzalex, is worth keeping an eye on for a number of reasons.

To Comfortably Beat The Market Dividend Growth Investors Should Consider CROIC

Gilead's (GILD) Cocktail HIV Drug Genvoya Approved in EU

Demographics Will Drive Future Investment Decisions

Playing the Ratings Game

This Metric Implies That It Might Be Time to Buy Big Pharma Stocks

This metric, signaling the exodus of a specific type of investor, implies that Big Pharma stocks could be ready to head higher

See More JNJ News...

JNJ's Top Competitors

JNJ $101.96 (-0.08%)
Current stock: JNJ
PFE $32.87 (2.82%)
Current stock: PFE
MRK $53.72 (0.45%)
Current stock: MRK
BSX $18.38 (0.33%)
Current stock: BSX